Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2016 1
2017 1
2021 2
2022 3
2023 2
2024 2
2025 6
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Trial of Intravenous Amino Acids for Kidney Protection.
Landoni G, Monaco F, Ti LK, Baiardo Redaelli M, Bradic N, Comis M, Kotani Y, Brambillasca C, Garofalo E, Scandroglio AM, Viscido C, Paternoster G, Franco A, Porta S, Ferrod F, Calabrò MG, Pisano A, Vendramin I, Barucco G, Federici F, Severi L, Belletti A, Cortegiani A, Bruni A, Galbiati C, Covino A, Baryshnikova E, Giardina G, Venditto M, Kroeller D, Nakhnoukh C, Mantovani L, Silvetti S, Licheri M, Guarracino F, Lobreglio R, Di Prima AL, Fresilli S, Labanca R, Mucchetti M, Lembo R, Losiggio R, Bove T, Ranucci M, Fominskiy E, Longhini F, Zangrillo A, Bellomo R; PROTECTION Study Group. Landoni G, et al. N Engl J Med. 2024 Aug 22;391(8):687-698. doi: 10.1056/NEJMoa2403769. Epub 2024 Jun 12. N Engl J Med. 2024. PMID: 38865168 Clinical Trial.
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA-IL PSO (Italian Landscape Psoriasis).
Valenti M, Ibba L, Di Giulio S, Dapavo P, Malagoli P, Marzano AV, Loconsole F, Burlando M, Balato A, Dini V, Megna M, Girolomoni G, Trovato E, Lasagni C, Travaglini M, Guarneri C, Zerbinati N, Ribero S, Gaiani FM, Carrera CG, Cozzani EC, Di Brizzi EV, Michelucci A, Potestio L, Maurelli M, Dragotto M, Mastorino L, Bongiovanni E, Messina F, Sechi A, Moroni R, Costanzo A, Narcisi A. Valenti M, et al. Dermatol Ther (Heidelb). 2025 Sep;15(9):2423-2437. doi: 10.1007/s13555-025-01476-1. Epub 2025 Jul 3. Dermatol Ther (Heidelb). 2025. PMID: 40608253 Free PMC article.
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.
Avallone G, Bombelli A, Gargiulo L, Foti C, Trave I, Rossi M, Magnaterra E, Pigliacelli F, Malagoli P, Giacalone S, Portarapillo A, Patruno C, Schettini N, Bonzano L, Pezzolo E, Chello C, Gori N, Brunasso G, Veronese F, Ortoncelli M, Tolino E, Azzolini A, Bellinato F, Hansel K, Di Brizzi EV, Gurioli C, Esposito M, Giuffrida R, Barei F, Calzari P, Burroni AG, Gola M, Mariano M, Fargnoli MC, Napolitano M, Grieco T, Peris K, Savoia P, Ribero S, Girolomoni G, Stingeni L, Balato A, Costanzo A, Marzano AV, Narcisi A, Ferrucci SM. Avallone G, et al. Dermatol Ther (Heidelb). 2025 Dec;15(12):3671-3688. doi: 10.1007/s13555-025-01550-8. Epub 2025 Oct 10. Dermatol Ther (Heidelb). 2025. PMID: 41071522 Free PMC article.
Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study.
Torres T, Sood S, Yilmaz O, Vender RB, Prajapati VH, Puig L, Megna M, Marzano AV, Gisondi P, Carrascosa JM, Dauden E, Llamas-Velasco M, Balato A, Leal BG, Prignano F, Bellinato F, Silvi G, Di Brizzi EV, Potestio L, Carrera CG, López-Ferrer A, Del-Alcazar E, Mufti A, Maul LV, Piaserico S, Maul JT, Yeung J. Torres T, et al. Dermatol Ther (Heidelb). 2026 Feb;16(2):701-707. doi: 10.1007/s13555-026-01653-w. Epub 2026 Jan 23. Dermatol Ther (Heidelb). 2026. PMID: 41575604 Free PMC article. No abstract available.
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg-IL PSO (Italian Landscape Psoriasis).
Valenti M, Ibba L, Di Giulio S, Gargiulo L, Malagoli P, Balato A, Bardazzi F, Loconsole F, Burlando M, Cagni AE, Cameli N, Carrera CG, Carugno A, Cuccia A, Dapavo P, Di Brizzi EV, Dini V, Fargnoli MC, Gaiani FM, Guarneri C, Lasagni C, Licata G, Marzano AV, Megna M, Mercuri SR, Michelucci A, Musumeci ML, Orsini D, Ortega R, Potestio L, Rapparini L, Ribero S, Satolli F, Strippoli D, Trovato E, Venturini M, Zichichi L, Brianti P, Costanzo A, Narcisi A. Valenti M, et al. Dermatol Ther (Heidelb). 2025 Jun;15(6):1427-1440. doi: 10.1007/s13555-025-01416-z. Epub 2025 Apr 23. Dermatol Ther (Heidelb). 2025. PMID: 40266488 Free PMC article.
Amino Acid Infusion for Kidney Protection in Cardiac Surgery Patients with Chronic Kidney Disease: A Secondary Analysis of the PROTECTION Trial.
Baiardo Redaelli M, Monaco F, Bradic N, Scandroglio AM, Ti LK, Belletti A, Viscido C, Licheri M, Guarracino F, Pruna A, Pisano A, Pontillo D, Federici F, Losiggio R, Serena G, Tomasi E, Silvetti S, Ranucci M, Brazzi L, Cortegiani A, Landoni G, Mastroroberto P, Paternoster G, Gaudino MFL, Zangrillo A, Bellomo R; for the PROTECTION Study Group Collaborators. Baiardo Redaelli M, et al. Anesthesiology. 2025 May 1;142(5):818-828. doi: 10.1097/ALN.0000000000005336. Epub 2024 Dec 19. Anesthesiology. 2025. PMID: 39705670 Clinical Trial.
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management.
Fazio N, Maisonneuve P, Frezza AM, Ranallo N, Ibrahim T, La Salvia A, Brizzi MP, De Divitiis C, Tafuto S, Pusceddu S, Marconcini R, Cives M, Ferrari C, Campana D, De Lisi D, Santini D, Faggiano A, Modica R, Massironi S, Bianchi A, Panzuto F, Antonuzzo L, Pellegrini E, Amoroso V, Puliafito I, Merola E, Silvestris N, Grana CM, Spada F. Fazio N, et al. J Neuroendocrinol. 2026 Jan;38(1):e70115. doi: 10.1111/jne.70115. Epub 2025 Nov 18. J Neuroendocrinol. 2026. PMID: 41255062 Free PMC article.
High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial.
Monti G, Konkayev A, Carta S, Bradic N, Bruni A, Kotani Y, Guarracino F, Redkin I, Biondi-Zoccai G, Benedetto U, D'Ascenzo F, Garofalo E, Baiardo Redaelli M, Brizzi G, Forfori F, Borghi G, Scapol S, Momesso E, Cuffaro R, Boffa N, Rauch S, D'Amico F, Montrucchio G, Pace MC, Galbiati C, Bosso S, Savelli F, Giardina G, Silvetti S, Tripodi VF, Labanca R, Lembo R, Marmiere M, Marzaroli M, Nakhnoukh C, Valsecchi D, Finco G, Agrò FE, Bove T, Corradi F, Longhini F, Landoni G, Bellomo R, Zangrillo A; Collaborators. Monti G, et al. Contemp Clin Trials. 2023 Oct;133:107319. doi: 10.1016/j.cct.2023.107319. Epub 2023 Aug 23. Contemp Clin Trials. 2023. PMID: 37625587 Free article.
19 results